| Name | Title | Contact Details |
|---|
Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.
Woodlyn Inc is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At LogicMark, we`re passionate about the peace of mind that comes from knowing your loved ones will be able to call for help in the event of an emergency. Our mission is to always apply the latest technologies for new and improved Personal Emergency Response Systems to help seniors enjoy much-deserved independence. Founded in 2006, LogicMark has revolutionized the personal emergency response system (PERS) industry by building patented two-way voice communication technology directly into the medical alert pendant. With a focus on innovation, LogicMark provides a unique offering of medical alert systems that contribute to improving the quality of life for those who want to continue living independently.
InterVene`s mission is to provide the first effective and widely-utilized therapy for patients suffering from the painful and costly symptoms of Chronic Venous Insufficiency (CVI) due to deep vein reflux (DVR).
Mededge Inc is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.